Official title: Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes Summary: Cigarette smoking is now the leading killer of people with HIV (PWH) in the US, and most cessation strategies tried to date have failed to increase long-term quit rates. An "all or none" approach to smoking cessation in PWH offers little benefit to the large majority of PWH who are unable or unwilling to quit.
In this proposal we argue that a harm reduction approach (i.e., cut down, get screened for lung cancer, control your blood pressure and cholesterol) has the potential to yield significant benefits in terms of the private and public health of PWH in the US. Conditions: Hiv, Tobacco Use Keywords: HIV, Tobacco, Cigarette, Smoking, Harm reduction Study type: INTERVENTIONAL Primary purpose: TREATMENT Phases: NA Enrollment: 400 (ESTIMATED) Status: RECRUITING Completion: 2027-03 (ESTIMATED)
ClinicalTrials.gov published a clinical update in Cardiology on 07 Jan 2026.
The item focuses on Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes.
Review the original article for the full source wording and details.